Aptivus® (tipranavir) HIV-1 Protease Inhibitor for Treatment-Experienced Patients

What Aptivus® Is and How It Works

Aptivus (tipranavir) is an HIV-1 protease inhibitor used with ritonavir and other antiretrovirals. It is for treatment-experienced adults and adolescents with resistant virus. If you seek an Aptivus online purchase, YouDrugstore offers a straightforward process, including support for patients buying Aptivus without insurance. You take it by mouth, usually twice daily with food.

YouDrugstore is a licensed Canadian pharmacy headquartered in Manitoba; prescriptions are reviewed by licensed pharmacists before dispensing.

We work with licensed, vetted international partner pharmacies so you can access authentic brand medicines, a broad selection, and affordable pricing.

Tipranavir blocks the HIV-1 protease enzyme. This prevents cleavage of viral polyproteins, which leads to immature, noninfectious virus. The medicine must be combined with ritonavir, which boosts blood levels of tipranavir by inhibiting CYP3A metabolism. Your prescriber builds an optimized background regimen using resistance testing and treatment history. Learn more about care for Hiv Infection on our site.

In Canada and the US, Aptivus is supplied as oral capsules and an oral solution. It is not used as first-line therapy, but as part of a salvage regimen when other options have failed. Consistent daily dosing supports viral suppression and helps prevent further resistance.

Dosage and Usage

• Adults: 500 mg tipranavir (usually two 250 mg capsules) plus 200 mg ritonavir, taken twice daily with food.
• Adolescents: dosing is weight-based; follow the specialist’s plan. The oral solution may be used when needed.
• Always take Aptivus with ritonavir at the same time. Do not use tipranavir alone.
• Swallow capsules whole with food. Do not crush or chew unless your prescriber directs otherwise.
• For oral solution, measure doses with a marked oral syringe. Shake the bottle well, then dose with food.
• If you miss a dose by less than 5 hours, take it with food as soon as you remember, then resume the schedule. If more than 5 hours late, skip and take the next dose on time.
• Do not double the next dose.
• If you vomit within a short time of dosing, ask your prescriber about whether to redose.
• Avoid high-dose vitamin E supplements, as Aptivus formulations contain vitamin E.
• Use effective contraception. Hormonal contraceptives may be less reliable with ritonavir-boosted regimens.

• Store capsules at 15–30 °C (59–86 °F). Keep the bottle tightly closed and dry.
• Store oral solution at room temperature. Do not freeze. Keep away from heat and direct sun.
• When travelling, keep Aptivus in your carry-on bag with original labels.
• Avoid leaving medicine in a parked car or in hot environments above 30 °C (86 °F).
• Bring enough medicine for your trip, plus extra for delays.
• Use a pill organizer if approved by your pharmacist, and keep one labeled bottle for security checks.

Benefits and Savings

For patients with resistant HIV-1, Aptivus can help achieve viral load reductions when combined with active background agents. Ritonavir boosting allows steady exposure. Twice-daily dosing with food fits many routines. Your clinician will monitor liver enzymes, lipids, and interactions.

Ordering through our Canadian online pharmacy offers strong value. Many customers report 60–80% savings compared with typical US prices. This can lower your ongoing Aptivus cost, and help if you are paying cash. We support patients buying Aptivus without insurance with clear pricing and documentation.

Multi-month supplies can reduce the per-month Aptivus price. You can set gentle reorder reminders in your account so you do not run out. From time to time we run bulk promotions that deliver an Aptivus discount without extra steps.

For current offers, see our Aptivus coupon information page.

Side Effects and Safety

• Nausea, vomiting, or stomach pain
• Diarrhea or loose stools
• Headache or fatigue
• Rash or itching
• Increased liver enzymes
• Increased blood lipids
• Loss of appetite or taste changes
• Cough or upper respiratory symptoms

Serious risks include severe hepatotoxicity (liver injury) and rare intracranial hemorrhage. Risk may be higher in those with hepatitis B or C, alcohol use, or pre-existing liver disease. Seek urgent care for severe abdominal pain, jaundice, unusual bruising, severe rash, or neurologic symptoms. Tipranavir has a sulfonamide structure; discuss prior sulfa allergy with your clinician. Increased bleeding can occur in patients with hemophilia.

Avoid rifampin, St. John’s wort, and other contraindicated drugs. Some statins (lovastatin, simvastatin) and ergot derivatives are unsafe with ritonavir-boosted regimens. Warfarin, anticonvulsants, and many other medicines need close monitoring. Use non-hormonal contraception or a reliable backup method. Read the full interaction list provided with your prescription.

Onset Time

With consistent dosing and an optimized background regimen, viral load often begins to fall within 2–4 weeks. By 8–12 weeks, many patients see clearer suppression on lab tests. CD4 counts may improve over several months. Your clinician will space lab checks to track response and adjust the regimen if needed.

Compare With Alternatives

Raltegravir is an integrase inhibitor used widely in combination therapy. It is taken once or twice daily and is well tolerated. You can review options like Isentress® with your prescriber when building a regimen.

Two-drug maintenance therapy may suit some stable, suppressed patients. One option combines dolutegravir and rilpivirine. See Juluca® for an overview to discuss with your HIV specialist.

Choice depends on resistance, tolerability, and drug interactions. Aptivus is typically reserved for resistant virus when other choices are limited. Your clinician will tailor therapy to your history and lab results.

Combination Therapy

• Aptivus must be co-administered with ritonavir, taken at the same time with food.
• Use with two or more additional active agents based on resistance testing.
• Coordinate dosing times to improve adherence and reduce missed doses.
• Review all medicines and supplements to avoid contraindicated combinations.
• Your care team may adjust background drugs to improve efficacy and safety.

Patient Suitability and Cost-Saving Tips

Aptivus may be considered for treatment-experienced adults and adolescents with documented resistance to multiple antiretroviral classes. It is not indicated for initial therapy in most patients. It is usually chosen when other protease or integrase options are compromised by resistance or intolerance.

Aptivus may not be appropriate for people with moderate or severe hepatic impairment, those with a history of intracranial hemorrhage, or those taking contraindicated medicines. Caution is needed in hepatitis B or C coinfection. Discuss pregnancy planning with your clinician. Where safe alternatives exist, people living with HIV are usually advised not to breastfeed.

To manage Aptivus cost, consider a larger supply if your prescription allows. Multi-pack orders can lower the monthly Aptivus price and reduce shipping fees. Turn on reorder reminders so you can plan refills ahead. If you are uninsured, ask about current promotions that may offer an Aptivus promo or sale price.

Authoritative Sources

FDA Prescribing Information for Aptivus (tipranavir)

Health Canada Drug Product Database (DPD)

Boehringer Ingelheim: Product Information

Order Aptivus® from YouDrugstore: add to cart, upload your prescription, and we ship with prompt, express shipping.

This information is educational and does not replace medical advice. Always consult your healthcare professional for diagnosis, treatment, and guidance tailored to you.